Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine

MeSH terms

• Adult
• Alemtuzumab
• Anemia, Hemolytic / etiology
• Anemia, Hemolytic / therapy
• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal, Humanized
• Antibodies, Monoclonal, Murine-Derived
• Antibodies, Neoplasm / administration & dosage
• Antigens, CD / analysis
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Biomarkers, Tumor / analysis
• Blood Transfusion
• Cladribine / administration & dosage
• Cyclophosphamide / administration & dosage
• Doxorubicin / administration & dosage
• Female
• Humans
• Liver Neoplasms / drug therapy*
• Lymphoma, T-Cell / complications
• Lymphoma, T-Cell / drug therapy*
• Neutropenia / etiology
• Prednisolone / administration & dosage
• Receptors, Antigen, T-Cell, gamma-delta / analysis
• Recurrence
• Remission Induction
• Rituximab
• Splenic Neoplasms / drug therapy*
• Vincristine / administration & dosage